# Vitamin D Deficiency & Hair Loss: What the Research Shows

> Vitamin D deficiency is found in over 50% of people with alopecia areata and female.

*Vitamin D and its receptor (VDR) play a documented role in hair follicle cycling. 51% with telogen effluvium. VDR is expressed in hair follicle keratinocytes and dermal papilla cells; in animal models VDR deletion alone causes complete alopecia, independent of vitamin D levels. Whether oral vitamin D supplementation produces hair regrowth in deficient humans remains under-studied — the association is clear, the therapeutic RCT evidence is limited. Testing 25-hydroxyvitamin D and correcting confirmed deficiency (< 20–30 ng/mL) is sensible, low-risk, and well-justified.*

- Canonical: https://beautycomparison.com/vitamin-d-hair-loss
- Reviewed: 2026-06-20
- Publisher: Beauty Comparison (Beauty Comparison Editorial) — independent, brand-neutral

## Key takeaways
- Vitamin D deficiency is found in more than half of people with alopecia areata, female pattern hair loss, and telogen effluvium — significantly more common than in people without hair loss.
- The vitamin D receptor (VDR) is expressed in hair follicle keratinocytes and dermal papilla cells and regulates the anagen-to-catagen transition of the hair cycle.
- In mouse models, deletion of the VDR gene alone — independent of vitamin D levels — causes complete alopecia, establishing the receptor as essential for hair follicle cycling.
- Correcting confirmed vitamin D deficiency (serum 25-OHD < 20 ng/mL) is recommended; the optimal range for general health is 30–60 ng/mL (75–150 nmol/L).
- Robust RCT evidence that vitamin D supplementation specifically reverses hair loss in humans is still limited — the association is well-documented, the direct therapeutic evidence is preliminary.
- Topical vitamin D analogs (calcipotriol) have shown adjunctive benefit in alopecia areata in small trials; oral supplementation trials are ongoing.

## Vitamin D and Hair Follicles: Why the Connection Matters

Vitamin D is not simply a bone-and-immune nutrient. The vitamin D receptor (VDR) is expressed throughout the skin — in keratinocytes, fibroblasts, dermal papilla cells, and hair follicle epithelial cells. This wide expression pattern suggests vitamin D plays a broader regulatory role in skin biology than its classical calcium-absorption function alone.

The hair follicle connection became particularly clear from transgenic mouse research: mice with a VDR gene deletion develop normally but then lose all body hair within weeks of birth. Crucially, this alopecia occurs even when vitamin D levels are normal — it is the receptor itself, independent of its ligand, that is required for the normal hair cycle. This finding positions VDR as intrinsically essential for hair follicle function in a way that goes beyond simply "correcting a vitamin deficiency."

In humans, the picture is more complex but directionally consistent.

---

## What the Epidemiological Evidence Shows

A 2024 systematic review and meta-analysis (PMC11479915) comprehensively mapped vitamin D status across multiple types of hair loss. Key findings:

| Hair Loss Type | Prevalence of Vitamin D Deficiency |
|---|---|
| Alopecia Areata (AA) | 51.94% |
| Female Pattern Hair Loss (FPHL) | 50.38% |
| Male Androgenetic Alopecia | 47.38% |
| Telogen Effluvium (TE) | 53.51% |
| Primary Scarring Alopecia | 38.85% |

These figures represent a consistently elevated rate of deficiency across hair loss types — substantially higher than background population deficiency rates in comparable demographics. The same meta-analysis confirmed an **inverse relationship between serum 25-OHD levels and non-scarring alopecias**: as vitamin D decreases, hair loss burden increases.

An earlier PMC-indexed systematic review of serum 25-OHD in non-scarring alopecia (PMC indexed 2023) similarly found lower mean vitamin D levels in alopecia patients versus controls across multiple studies.

### Important Caveat

These are observational associations. They demonstrate a link between low vitamin D and hair loss, but they do not prove that correcting vitamin D deficiency will independently reverse hair loss. Deficiency may be a contributor among multiple causes (genetics, DHT sensitivity, inflammation, other nutritional gaps) rather than a singular driver.

---

## How Vitamin D Regulates the Hair Cycle

The hair follicle cycles through four phases: anagen (active growth), catagen (regression), telogen (rest), and exogen (shedding). VDR signaling is involved in the anagen-to-catagen transition and in keratinocyte differentiation within the follicle.

Proposed mechanisms:

**1. VDR and the hair cycle clock**
VDR regulates expression of genes involved in follicular cycling, including components of the Wnt/β-catenin pathway — a central signaling axis for anagen initiation and maintenance. Disrupted VDR expression shortens or prevents anagen re-entry.

**2. Immunomodulation in Alopecia Areata**
Alopecia areata is an autoimmune condition in which cytotoxic T cells attack the hair follicle. Vitamin D exerts broad immunomodulatory effects: it suppresses Th1 and Th17 inflammatory responses, increases regulatory T cells (Tregs), and promotes immune tolerance at the follicle. A 2025 PMC review (PMC12105854) found that vitamin D3 can decrease the autoimmune trigger of AA by shifting immune response from Th1 to Th2 phenotype and increasing Treg activity. This is a pharmacologically plausible mechanism — not just an association.

**3. Dermal Papilla and Follicle Survival**
VDR is expressed in dermal papilla cells, which orchestrate follicle growth by signaling to the overlying epithelium. In vitro studies have shown that vitamin D promotes follicle survival and may extend anagen by supporting dermal papilla cell function.

---

## Alopecia Areata: The Strongest Human Evidence

Among all hair loss types, the relationship between vitamin D and alopecia areata (AA) is best documented, likely because AA is immunologically driven and vitamin D's immunomodulatory role is well characterized.

A 2025 systematic review and meta-analysis (PMC12854560) specifically examined vitamin D and its analogs in treatment of mild-to-moderate AA. Findings:
- Vitamin D3 supplementation and topical analogs showed potential benefit as adjunctive treatments
- Topical calcipotriol (a vitamin D analog) has been studied in small trials with signals of improvement in patch AA
- Oral vitamin D supplementation in deficient patients with AA may reduce severity and relapse rates

**What this means in practice:** Patients with alopecia areata who have vitamin D deficiency have biological justification for correction — and potentially for VDR-targeting with topical analogs under dermatological supervision.

---

## Female Pattern Hair Loss and Telogen Effluvium

For FPHL and TE, the evidence for therapeutic supplementation is less developed:

- **Female Pattern Hair Loss:** Observational data shows lower vitamin D in FPHL patients versus controls. The primary driver of FPHL is androgen-driven miniaturization (DHT sensitivity), not vitamin D deficiency per se. Correcting deficiency may support the broader follicle environment but is unlikely to reverse established miniaturization on its own.

- **Telogen Effluvium:** TE from physiological stresses (illness, childbirth, surgery, dietary restriction) often co-occurs with multiple nutritional deficiencies simultaneously. Correcting vitamin D alongside iron (the more directly impactful deficiency for TE) is a reasonable part of a comprehensive approach.

---

## Testing: What to Measure and What the Numbers Mean

**The right test:** Serum **25-hydroxyvitamin D** (25-OHD) — this reflects total vitamin D status from both sun exposure and diet/supplementation. Do not measure 1,25-dihydroxyvitamin D (the active form) for deficiency assessment — it is tightly regulated and normal even in severely depleted patients.

**Reference ranges — what they mean for hair:**

| 25-OHD Level | Classification | Hair-Loss Context |
|---|---|---|
| < 10 ng/mL (< 25 nmol/L) | Severe deficiency | High risk; correct urgently |
| 10–20 ng/mL (25–50 nmol/L) | Deficiency | Common in hair loss patients; correct |
| 20–30 ng/mL (50–75 nmol/L) | Insufficiency | Borderline; consider supplementing |
| 30–60 ng/mL (75–150 nmol/L) | Adequate / Optimal | Target range for repletion |
| > 100 ng/mL (> 250 nmol/L) | Potential toxicity range | Avoid supplementation to this level |

**Testing note:** Request the test as "25-hydroxyvitamin D total" or "25-OHD." Some labs report in nmol/L (international units) rather than ng/mL; to convert ng/mL → nmol/L, multiply by 2.496.

---

## Supplementing Vitamin D: What to Take and How Much

### Vitamin D3 vs. D2

**Vitamin D3 (cholecalciferol)** is the form produced by skin on sun exposure and is substantially more effective than D2 (ergocalciferol) at raising and maintaining serum 25-OHD levels. Choose D3.

### Dosing for Deficiency Correction

Dosing depends on baseline levels and is best guided by a physician or dietitian. General evidence-based guidance:

| Baseline 25-OHD | Typical Repletion Dose | Duration to Retest |
|---|---|---|
| < 10 ng/mL | 4,000–5,000 IU/day (or physician-prescribed loading regimen) | 3 months |
| 10–20 ng/mL | 2,000–4,000 IU/day | 3 months |
| 20–30 ng/mL | 1,000–2,000 IU/day | 3–6 months |
| 30–60 ng/mL (maintenance) | 400–1,000 IU/day | Annual testing |

### Vitamin D Toxicity

True vitamin D toxicity (hypervitaminosis D) requires sustained very high intake — typically >10,000 IU/day for months — and is rare at typical supplementation doses. However, some commercial "hair nutraceuticals" stack vitamin D at 2,000–5,000 IU atop any dietary intake; if you take multiple products, add up your total daily vitamin D and stay below the Tolerable Upper Intake Level of 4,000 IU/day without medical supervision.

### Vitamin D and Calcium: The Cofactor Relationship

Vitamin D promotes calcium absorption. High-dose supplementation without adequate calcium and magnesium can theoretically shift calcium balance. People with a history of kidney stones should be cautious and discuss with their physician.

### Vitamin K2: Why Some Experts Recommend Pairing It

Vitamin D3 promotes calcium absorption; vitamin K2 (MK-7 form) directs calcium to bone rather than soft tissue. Some practitioners recommend combining D3 with K2 at doses above 2,000 IU/day, particularly in people at risk of arterial calcification. The evidence for this combination for hair is indirect but the safety rationale is sound.

---

## How Long Before Vitamin D Improves Hair?

Serum 25-OHD responds to supplementation within 6–8 weeks at therapeutic doses. Hair improvement — if it occurs — will lag because the hair cycle must catch up. Realistic expectations:

- **2–3 months:** 25-OHD levels corrected; shedding may begin to stabilize
- **4–6 months:** Potential improvement in hair density if vitamin D was a significant contributor
- **6–12 months:** Full benefit assessment; hair cycle latency means earlier assessment is premature

If hair loss continues to worsen despite corrected vitamin D, the deficiency was likely a contributor rather than the primary cause — and other factors (DHT, autoimmunity, iron deficiency) should be investigated or treated in parallel.

---

## Integrating Vitamin D into a Hair Loss Treatment Plan

Vitamin D correction is an important adjunct, not a standalone treatment. For most forms of hair loss:

1. **Test 25-OHD** alongside ferritin, TSH, and zinc in any hair loss workup
2. **Correct to 30–60 ng/mL** with D3 supplementation
3. **Treat the primary driver:** For AA, consult a dermatologist for appropriate immunotherapy; for FPHL, [topical minoxidil](/minoxidil-women-guide) has the strongest OTC evidence; for TE, address the trigger and correct all nutritional deficiencies concurrently
4. **Retest at 3 months** to confirm 25-OHD response
5. **Maintain** with 1,000–2,000 IU daily ongoing; monitor annually

See [/hair-loss-supplements-guide](/hair-loss-supplements-guide) for the complete evidence-ranked view of supplements, and [/ferritin-levels-hair-loss](/ferritin-levels-hair-loss) for the iron/ferritin deep-dive — often the more actionable deficiency in women.

## FAQ
**What does the latest research say about vitamin D and hair loss in 2026?**

A 2024 systematic review (PMC11479915) confirmed vitamin D deficiency in 51.94% of alopecia areata patients, 50.38% with female pattern hair loss, and 53.51% with telogen effluvium. A 2025 review (PMC12105854) mapped the mechanism more clearly, showing VDR modulates immune privilege at the hair follicle and that vitamin D3 shifts the autoimmune response driving alopecia areata. The association between deficiency and hair loss is well-established; the therapeutic RCT evidence for supplementation-specific hair regrowth is still accumulating.

**What vitamin D level should I aim for to support hair health?**

The general target for repletion is 30–60 ng/mL (75–150 nmol/L) of 25-hydroxyvitamin D. Most experts consider < 20 ng/mL (50 nmol/L) deficient, and < 30 ng/mL insufficient. Given that the majority of hair loss patients in multiple studies fall below 30 ng/mL, this range is the practical target. Testing your baseline before supplementing is important — some people are already adequate and gain no benefit from additional supplementation.

**Can vitamin D supplements regrow hair?**

In people who are genuinely deficient, correcting vitamin D may support the conditions for better hair follicle function — particularly relevant in alopecia areata, where the immunomodulatory role of vitamin D is well documented. However, robust RCTs demonstrating measurable hair regrowth specifically from oral vitamin D supplementation in humans are limited. The evidence supports correction of deficiency as part of a broader approach; it does not support vitamin D supplementation as a standalone treatment for hair loss in well-nourished individuals.

**What is the VDR and why does it matter for hair?**

The vitamin D receptor (VDR) is a nuclear receptor expressed in hair follicle keratinocytes and dermal papilla cells. When VDR binds activated vitamin D (1,25-dihydroxyvitamin D), it regulates gene expression involved in cell differentiation, immune modulation, and crucially — the hair cycle. Mouse studies show VDR gene deletion alone causes complete alopecia even when vitamin D levels are normal, establishing the receptor as intrinsically required for hair follicle cycling, independent of the vitamin itself.

**Should I take vitamin D with vitamin K2?**

Many practitioners recommend combining vitamin D3 with vitamin K2 (MK-7 form) at doses above 2,000 IU/day. The rationale: vitamin D promotes calcium absorption, and K2 directs that calcium to bone rather than soft tissues (arteries, kidneys). The safety logic is sound, though K2's hair-specific benefit is indirect. Pairing D3 with 100–200 µg K2 MK-7 at supplemental doses is a reasonable and widely recommended approach.

**Is sun exposure enough to correct vitamin D deficiency for hair health?**

In theory, sun exposure triggers skin synthesis of vitamin D3 — but in practice, the amount produced depends heavily on latitude, season, skin pigmentation, clothing, sunscreen use, and age. In northern latitudes (UK, northern US, Canada, Scandinavia), meaningful synthesis is only possible April–September between 10 am and 3 pm with exposed skin. People with darker skin tones require longer exposure for equivalent synthesis. Most people with confirmed deficiency need supplementation, not just sun — and avoiding sunburn is important regardless.

## Sources
- Vitamin D Deficiency in Non-Scarring and Scarring Alopecias: A Systematic Review and Meta-Analysis — PubMed Central (2024-10-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC11479915/
- Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications — PubMed Central (2025-05-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC12105854/
- The Role of Vitamin D Receptor Signaling in Hair Follicle Health and Alopecia: Current Understanding and Therapeutic Implications — PubMed Central / NIH (2025-01-01): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12747802/
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis — PubMed Central (2025-01-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC12854560/
- Diet and Hair Loss: Effects of Nutrient Deficiency and Supplement Use — PubMed Central (2017-03-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC5315033/
- Role of Vitamin D in Hair Loss: A Short Review — PubMed (2021-09-01): https://pubmed.ncbi.nlm.nih.gov/34553483/

_Health information, not medical advice._